Skip to content

New partnerships aim to raise quality standards in Indian healthcare

By News Analysis India · · 1 min read

On July 23 in New Delhi, the Indian Pharmacopoeia Commission (IPC) reinforced its commitment to health‑sector quality and innovation by signing two fresh MoUs with Dr. Shakuntala Mishra National Rehabilitation University (DSWMRU) and the CSIR‑Central Institute of Medicinal and Aromatic Plants (CSIR‑CIMAP). The ceremony featured DSWMRU Vice‑Chancellor Prof. Sanjay Singh, IPC’s Secretary‑Scientific Director Dr. V. Kalaiselvan and senior CSIR‑CIMAP officials.

The CSIR‑CIMAP agreement will sustain collaborative research on medicinal plants, standardisation procedures and rigorous quality testing of herbal medicines. Meanwhile, the DSWMRU MoU is designed to craft scientific protocols for assessing assistive devices used by people with disabilities, ensuring they meet stringent safety and performance criteria. It also includes a plan to develop a pharmacovigilance training module in a visual language to promote drug‑safety awareness and better reporting of adverse reactions among disabled users.

According to Dr. Kalaiselvan, these joint efforts will boost research capacity, enforce higher quality standards and deepen partnership networks, helping Uttar Pradesh emerge as a benchmark state for health‑service excellence. He stressed that such steps are vital for the broader “Developed UP, Developed India” agenda, improving access to safe and effective health products across the nation.